Collectively, this dual metabolic identity, preserving physiological specialization in citrate production while hijacking polyamine and citrate pathways for oncogenic rewiring, not only distinguishes PCa from other malignancies but also unveils targetable vulnerabilities for diagnostic and therapeutic innovation
However, this feature is also exploited by cancer cells to acquire drug resistance and improve their survival
This latter fact indicates that a resistance to the peptide is unlikely to arise and that longer-term treatment would result in even greater weight loss
In reality, appropriate use of any investigational peptide depends on factors a licensed provider evaluates directly
Characteristics of the set composition and parameters Mechanism of action at the molecular level In the preclinical literature, BPC-157 is described as a multidirectional compound the literature indicates six complementary axes of molecular activity
Licenciado por la Universidad de Granada